3D Printing Industry | 11/29/2018 | Umair Iftikhar

Clinicians of various specialties require autologous implantable tissues to repair and replace damaged tissue caused by diseases or trauma. With 3D bioprinting it is possible to manufacture such tissues, however, its biomechanical characteristics reduce its capabilities to be sutured.

As a result, 3D.FAB, a French additive manufacturing platform, is developing a “living bandage” using 3D bioprinting and direct additive manufacturing. According to the platform’s project “STRESSKIN,” such technologies can be positioned in this field of regenerative and personalized medicine to address this issue.

Focuses - Innovation - Field - Health - Platform

3D.FAB focuses on technological academic innovation in the field of health. In particular, the platform holds two main areas of expertise; the first includes biochemistry, especially diagnosis with prototyping 3D lab-on-chip, novel materials for 3D medical devices, biocompatible polymers, and cell-size 3D printing. The second attends to regenerative medicine through bioprinting living tissues.

One of several private projects from 3D.FAB, STRESSKIN aims to create innovative solutions to elevate the mechanical properties of bio-printed tissues towards biomimetic properties. “Once acquired, the applications will be vast and allow a multitude of specialists to find autologous and sustainable solutions to replace and repair tissue,” states 3D.FAB.

Bandage - Bioink - BioAssemblyBot - Arm

The 3D printed bandage is from a cell-based bioink. Using a BioAssemblyBot, a 6-axis robotic arm for...
(Excerpt) Read more at: 3D Printing Industry
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!